ClinicalTrials.gov
ClinicalTrials.gov Menu

LGBT Internet Based Smoking Treatment - 1

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00111501
Recruitment Status : Completed
First Posted : May 23, 2005
Last Update Posted : March 6, 2015
Sponsor:
Collaborator:
National Institute on Drug Abuse (NIDA)
Information provided by (Responsible Party):
University of California, San Francisco

Brief Summary:
The overall goals of this line of research are to develop and evaluate innovative treatments for lesbian, gay, bisexual, and transgender (LGBT) cigarette smokers and to understand the processes related to smoking and relapse in this previously unstudied population of smokers. In this study, participants are randomly assigned to one of two Internet-based smoking cessation treatments: 1) a self-help intervention tailored LGBT smokers plus social support plus email-based counseling, or 2) a standard self-help condition alone, similar to other general smoking cessation treatments. Before starting the program, participants will complete measures of smoking, nicotine dependence, depression diagnosis, demographics, mood, motivation to change, and alcohol use. Smoking status will be determined at 1, 3, 6, and 12 months following the start of treatment. Data will be analyzed to compare the quit rates of the two Internet-based treatment groups. Also, we will complete exploratory analyses to determine those variables that best predict quitting for LGBT smokers.

Condition or disease Intervention/treatment Phase
Tobacco Use Disorder Behavioral: Tobacco Use Disorder Behavioral: Standard Web-based intervention Phase 3

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 792 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: LGBT Internet Based Smoking Treatment
Study Start Date : September 2002
Actual Primary Completion Date : January 2009
Actual Study Completion Date : January 2009

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Smoking

Arm Intervention/treatment
Experimental: Targeted Internet Intervention
Web-based self help intervention developed to include specific cultural tailoring relevant to the LGBT community
Behavioral: Tobacco Use Disorder
Web-based psychoeducational intervention culturally-tailored to the LGBT community including a social support component

Active Comparator: Standard Intervention
Standard self-help internet-based intervention with no LGBT relevant information included
Behavioral: Standard Web-based intervention
General psychoeducational Web-based smoking cessation intervention




Primary Outcome Measures :
  1. point-prevalence abstinence from tobacco use [ Time Frame: 7-day ]
    Self-report of smoking status during the past seven days.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria
Must identify as a lesbian, gay male, bisexual male or female or a transgender individual. Must smoke most days during the preceding month. Must have a valid email address.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00111501


Locations
United States, California
University of California San Francisco Medical Cen
San Francisco, California, United States, 94143 0939
Sponsors and Collaborators
University of California, San Francisco
National Institute on Drug Abuse (NIDA)
Investigators
Principal Investigator: Gary Humfleet, Ph.D. University of California, San Francisco

Responsible Party: University of California, San Francisco
ClinicalTrials.gov Identifier: NCT00111501     History of Changes
Other Study ID Numbers: NIDA-15791-1
R01DA015791 ( U.S. NIH Grant/Contract )
R01-15791-1
First Posted: May 23, 2005    Key Record Dates
Last Update Posted: March 6, 2015
Last Verified: March 2015

Keywords provided by University of California, San Francisco:
smoking
tobacco

Additional relevant MeSH terms:
Tobacco Use Disorder
Substance-Related Disorders
Chemically-Induced Disorders
Mental Disorders